Related Experiment Video
Updated: Aug 11, 2026

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
Published on: October 6, 2019
Aberrant alternative splicing of interferon regulatory factor-1 (IRF-1) in myelodysplastic hematopoietic progenitor
Christos I Maratheftis1, Pelagia E Bolaraki, Stavroula Giannouli
1Department of Pathophysiology, Medical School, National University of Athens, 75 M. Asias St., Goudi, 11527 Athens, Greece.
Abstract:
Interferon regulatory factor-1 (IRF-1) mRNA expression was examined in specific cell populations (BMMC, CD34+ and CD71+) derived from 45 MDS patients and 20 controls. All the MDS cell populations, presented an identical IRF-1 mRNA expression pattern, characterized by the absence of full-length IRF-1 mRNA and presence of multiple alternative transcripts. The most common deletions involved exons 2 and 3. Two novel truncated IRF-1 protein forms were detected in MDS BMMC. IRF-1-induced iNOS mRNA expression was exclusively detected in BMMC having full-length transcript. The expression of IRF-1 truncated mRNA and protein forms might be a critical event in the development of MDS.
Insights
Myelodysplastic syndromes (MDS) show altered Interferon regulatory factor-1 (IRF-1) mRNA expression, with absent full-length transcripts and presence of truncated forms. These alterations may play a critical role in MDS development.
Area of Science:
- Molecular biology
- Hematology
- Oncology
Background:
- Interferon regulatory factor-1 (IRF-1) is a transcription factor involved in immune responses and cell differentiation.
- Dysregulation of IRF-1 has been implicated in various cancers, but its role in myelodysplastic syndromes (MDS) is not fully understood.
Purpose of the Study:
- To investigate the expression patterns of IRF-1 mRNA and protein in different cell populations from MDS patients.
- To determine the functional consequences of altered IRF-1 expression in MDS.
Main Methods:
- Analysis of IRF-1 mRNA expression in bone marrow mononuclear cells (BMMC), CD34+ and CD71+ cells from 45 MDS patients and 20 controls using RT-PCR.
- Detection of novel truncated IRF-1 protein forms in MDS BMMC.
- Examination of IRF-1-induced inducible nitric oxide synthase (iNOS) mRNA expression.
Main Results:
- All MDS cell populations exhibited an absence of full-length IRF-1 mRNA and the presence of multiple alternative transcripts, with common deletions in exons 2 and 3.
- Two novel truncated IRF-1 protein forms were identified in MDS BMMC.
- IRF-1-induced iNOS mRNA expression was only observed in BMMC with full-length IRF-1 transcript.
Conclusions:
- Altered expression of IRF-1, including truncated mRNA and protein forms, is a characteristic feature of MDS.
- The absence of full-length IRF-1 and the presence of truncated forms may be critical events in the pathogenesis of MDS.
- The loss of functional IRF-1 may impair the induction of downstream genes like iNOS, potentially contributing to MDS development.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Differentiation of Common Myeloid Progenitor Cells
Regulation of the Unfolded Protein Response
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
piRNA - Piwi-interacting RNAs

